Report Company Directory
- ZimVie Reports First Quarter 2024 Financial Results by GlobeNewsWire
- U.S. Medical Supplies & Devices: Recap & Preview – Recap & Preview – Wk# 3 of MedTech Earnings Drives Flat Group Perf vs. 1.6% for the S&P 500; GMED, PODD and ZIMV On Deck by Barclays
- U.S. Medical Devices & Supplies: ISASS Points to Stabilizing GMED+NUVA Dis-Synergies, Highlights Rising Interest in Endoscopic Spine and Motion Preservation by Barclays
- ZimVie to Report First Quarter Financial Results on May 8, 2024 by GlobeNewsWire
- U.S. Medical Supplies & Devices: Recap & Preview – Upside in Devices from JNJ, ABT and ISRG; New dV5 is a ‘Win’; Wk 2 Earnings Up Next (BSX, DXCM, EW) and More GMED and Spine Mkt Checks at ISASS by Barclays
- U.S. Medical Supplies & Devices: Why We See the ‘SYK vs. ISRG’ Buzz Around da Vinci 5 as a False Match-Up – Early Take-Aways from SAGES Day 1 by Barclays
- U.S. Medical Supplies & Devices: UPDATE: Q1 MedTech Group Performance Positioned to Beat Street Expectations by Barclays
- U.S. Medical Supplies & Devices: Recap & Preview – IMAST Pos for GMED; We Expect JNJ, ABT and ISRG Earnings to Feature Healthy Volumes; dV 5 Expected to Capture Spotlight at SAGES by Barclays
- U.S. Medical Devices & Supplies: Take-Aways from IMAST Mtg are Encouraging for GMED, Volume Comments Positive for Spine by Barclays
- U.S. Medical Supplies & Devices: Recap & Preview – JNJ Makes SWAV Deal ‘Official’, SMART Trial Sparks Excitement and Debate, BAX Next-Gen Pump Approved by Barclays